Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction-Reference-Cited by-同舟云学术

Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction

Published:2023-02 Issue: Volume:Volume 17 Page:313-330
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhang Jiehan^ORCID,Li Hongrong,Wang Dandong,Gu Jiaojiao,Hou Yunlong^ORCID,Wu Yiling^ORCID

Publisher

Informa UK Limited

Reference37 articles.

1. Efficacy and safety of Shen-Song-Yang-Xin capsule for treating arrhythmia in the elderly patients with coronary heart disease

2. Emerging molecular therapies targeting myocardial infarction-related arrhythmias

3. New Therapeutic Targets in Cardiology

4. Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling

5. Pathological Ventricular Remodeling

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of shensong yangxin capsules for persistent atrial fibrillation: a Systematic Review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2025-06-18

2. Traditional Chinese Medicine for Anti‐Arrhythmias: Mechanisms via Potassium Channels;Basic & Clinical Pharmacology & Toxicology;2025-06-03

3. Pre-procedural abnormal von Willebrand factor function predicts clinical outcomes after Transcatheter Aortic Valve Implantation: a prospective cohort study;Frontiers in Cardiovascular Medicine;2025-05-23

4. Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization;Advanced Science;2025-04-04

5. Traditional Chinese medicine: cardiovascular drug development through a holistic framework;European Heart Journal;2024-09-17